Specialty Pharmacy

US Marshals have seized $1.5 million worth of unapproved prescription drugs from Stratus Pharmaceuticals at the request of the FDA and the US attorney for the Southern District of Florida.

The FDA is considering approval for a liquid bendamustine hydrochloride rapid infusion product.

A record 4.3 billion prescriptions were filled in the United States last year.

Treatment found to lower blood sugar levels in obese mice.

Treatment dramatically reduces viral load in blood.

Low temperature plasmas found to induce high levels of DNA damage.

FDA warns of potential issues from diabetes drugs Onglyza, Kombiglyze, and Nesina.

When reporting diet and exercise, patients may feel pressured to say what they think clinicians want to hear.

Inhibiting a previously undruggable protein holds promise for treatment of numerous types of cancer.

Longer telomeres gives cancer cells a survival advantage.

Gilead Sciences is seeking FDA approval for emtricitabine/tenofovir alafenamide.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses innovative new therapies for the treatment of cancer.

CCZ impairs the ability of the virus to enter human liver cells.

Ibrutinib found to control Waldenstrom's Macroglobulinemia in 95% of patients.

Analysis of cancer-causing mutations in the BRCA1 or BRCA2 genes may lead to more effective treatments.

Lack of adherence remains a major source of health care costs among HIV patients.

Study finds that UV tanning meets the same criteria as smoking as a cause of cancer.

New FDA-approved drug used to treat patients with chronic iron overload.

Staying abreast of changes to the 340B Drug Pricing Program is critical for maintaining program compliance.

Accelerated aging of DNA can lead to diseases such as cancer and osteoporosis.

Increased neuron activity helps to protect nerve fibers.

New software platform will complement existing pharmacy software and optimize patient management.

The FDA refused to approve Novo Nordisk's ultra-long-acting insulin treatments 2 years ago.

Vast majority of children with HIV experience recovery of immune system following therapy.

Researchers suggest financial incentives to reward patient-centered care.

Companies to jointly market software to health care providers.

The FDA has granted orphan drug designation to Prolong Pharmaceuticals' sickle cell disease treatment.

Enzyme blocker reduces growth of intestinal tumors.